USFDA approval for Marksans Pharma Cetirizine Hydrochloride Tablets
Summary : Marksans Pharma Limited (Reuters: MARK.BO; Bloomberg: MRKS IN; NSE: MARKSANS; BSE: 524404) has received final approval from US Food &…
Summary : Marksans Pharma Limited (Reuters: MARK.BO; Bloomberg: MRKS IN; NSE: MARKSANS; BSE: 524404) has received final approval from US Food &…
Summary : The international systems for trademark and design protection continues to grow with Jamaica the latest country to file instruments of…
Highlights – Presbyopia, or age-related blurry near vision, is a common, progressive condition that reduces the eye’s ability to focus on near…
Summary : Anupam Rasayan India, a custom synthesis & speciality chemical firm, has signed a letter of intent (LoI) worth $95 million…
Synopsis: –By 2025, the company aims to generate $60 billion in pharma sales, leaning mostly on existing medicines for growth until then,…
Synopsis: The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary…
Summary : -The National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination (FAD) recommending Rinvoq (upadacitinib) 15mg…
Synopsis : TARZED is considered safe and more efficacious compared to conventional treatment medicines for breast cancer. Cadila Pharmaceuticals Limited on Wednesday…
Summary : –Nordic Nanovector ASA (OSE: NANOV) provides an update on the timeline for PARADIGME, its ongoing pivotal Phase 2b trial of Betalutin® (177Lu…
Summary : Rigel Pharmaceuticals, Inc. Inducement Plan, as amended, with a grant date of January 6, 2022, as an inducement material to…